ICD10 code of Budd-Chiari Syndrome and ICD9 code

Budd-Chiari syndrome is classified under the ICD-10 code I82.0 (Budd-Chiari syndrome) and the ICD-9 code 453.0 (Budd-Chiari syndrome). These codes are used by healthcare systems worldwide to standardize the medical billing and clinical documentation for this rare hepatic venous outflow obstruction.

What is the clinical significance of Budd-Chiari syndrome?

Budd-Chiari syndrome is a rare, life-threatening condition characterized by the obstruction of hepatic venous outflow, which prevents blood from draining properly from the liver. This blockage leads to increased pressure in the liver, resulting in a triad of symptoms: abdominal pain, ascites (fluid buildup in the abdomen), and hepatomegaly (enlarged liver). Because Budd-Chiari syndrome can progress rapidly to liver failure, accurate diagnostic coding—such as using ICD-10 I82.0—is essential for ensuring patients receive appropriate care and access to specialized treatments like transjugular intrahepatic portosystemic shunts (TIPS) or liver transplantation.

How is Budd-Chiari syndrome diagnosed and classified?

Diagnosis of Budd-Chiari syndrome usually begins with abdominal ultrasound with Doppler imaging to visualize the hepatic veins and the inferior vena cava. Clinical management is complex, often requiring a multidisciplinary team of hepatologists, interventional radiologists, and hematologists. While ICD-10 I82.0 is the primary code for Budd-Chiari syndrome, clinicians must also identify the underlying cause, as many cases are associated with thrombophilia, polycythemia vera, or other prothrombotic states. Within the DiseaseMaps.org community, 48 people living with Budd-Chiari syndrome have shared their experiences, highlighting the importance of early detection and specialized management.

What are the key clinical features of Budd-Chiari syndrome?

The presentation of Budd-Chiari syndrome varies significantly based on whether the blockage is acute, subacute, or chronic. Patients may experience a range of systemic issues due to the underlying venous obstruction. Common clinical indicators include:

• Ascites: Significant fluid accumulation in the peritoneal cavity.


• Hepatomegaly: Tenderness and enlargement of the liver upon physical examination.


• Abdominal Pain: Often acute and localized to the right upper quadrant.


• Jaundice: Yellowing of the skin and eyes, signaling impaired liver function.


• Splenomegaly: Enlargement of the spleen resulting from portal hypertension.

Is there a genetic component to Budd-Chiari syndrome?

While Budd-Chiari syndrome is not typically considered a hereditary genetic disease in the traditional sense, it is frequently caused by underlying inherited or acquired thrombophilic conditions. Genetic counseling is often recommended for patients diagnosed with Budd-Chiari syndrome to screen for conditions such as Factor V Leiden mutation, Prothrombin gene mutation, or Protein C and S deficiencies. Identifying these genetic predispositions is crucial for long-term anticoagulation therapy and preventing recurrent thrombosis.

Next steps

• Consult with a board-certified hepatologist or a gastroenterologist specializing in liver disease.


• Request a full hematological workup to identify any underlying prothrombotic conditions.


• Connect with the 48 community members on DiseaseMaps.org to share experiences and coping strategies.


• Discuss the necessity of regular Doppler ultrasound monitoring with your medical team.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Budd-Chiari syndrome (ORPHA:132)


• NIH Genetic and Rare Diseases (GARD) Information Center: Budd-Chiari syndrome


• OMIM (Online Mendelian Inheritance in Man): Budd-Chiari Syndrome (#600880)


• American Association for the Study of Liver Diseases (AASLD) Clinical Practice Guidelines